Literature DB >> 23643298

Surgery for metastatic neuroendocrine tumors with occult primaries.

Edmund K Bartlett1, Robert E Roses, Meera Gupta, Parth K Shah, Kinjal K Shah, Salman Zaheer, Heather Wachtel, Rachel R Kelz, Giorgos C Karakousis, Douglas L Fraker.   

Abstract

INTRODUCTION: Neuroendocrine tumors (NETs) frequently metastasize prior to diagnosis. Although metastases are often identifiable on conventional imaging studies, primary tumors, particularly those in the midgut, are frequently difficult to localize preoperatively.
MATERIALS AND METHODS: Patients with metastatic NETs with intact primaries were identified. Clinical and pathologic data were extracted from medical records. Primary tumors were classified as localized or occult based on preoperative imaging. The sensitivities and specificities of preoperative imaging modalities for identifying the primary tumors were calculated. Patient characteristics, tumor features, and survival in localized and occult cases were compared.
RESULTS: Sixty-one patients with an intact primary tumor and metastatic disease were identified. In 28 of these patients (46%), the primary tumor could not be localized preoperatively. A median of three different preoperative imaging studies were utilized. Patients with occult primaries were more likely to have a delay (>6 mo) in surgical referral from time of onset of symptoms (57% versus 27%, P = 0.02). Among the 28 patients with occult primary tumors, 18 (64%) were found to have radiographic evidence of mesenteric lymphadenopathy corresponding, in all but one case, to a small bowel primary. In all but three patients (89%), the primary tumor could be identified intraoperatively.
CONCLUSION: The primary tumor can be identified intraoperatively in a majority of patients with metastatic NETs, irrespective of preoperative localization status. Referral for surgical management should not, therefore, be influenced by the inability to localize the primary tumor.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carcinoid; Metastatic neuroendocrine tumor; Occult primary

Mesh:

Year:  2013        PMID: 23643298     DOI: 10.1016/j.jss.2013.04.008

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  12 in total

1.  Small Bowel Neuroendocrine Tumors.

Authors:  Catherine G Tran; Scott K Sherman; James R Howe
Journal:  Curr Probl Surg       Date:  2020-05-15       Impact factor: 1.909

2.  Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors.

Authors:  Kendall J Keck; Jessica E Maxwell; Yusuf Menda; Andrew Bellizzi; Joseph Dillon; Thomas M O'Dorisio; James R Howe
Journal:  Surgery       Date:  2016-11-15       Impact factor: 3.982

Review 3.  The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society.

Authors:  James R Howe; Kenneth Cardona; Douglas L Fraker; Electron Kebebew; Brian R Untch; Yi-Zarn Wang; Calvin H Law; Eric H Liu; Michelle K Kim; Yusuf Menda; Brian G Morse; Emily K Bergsland; Jonathan R Strosberg; Eric K Nakakura; Rodney F Pommier
Journal:  Pancreas       Date:  2017-07       Impact factor: 3.327

4.  Performance of Multidetector Computed Tomography and Negative Versus Positive Enteric Contrast for Evaluation of Gastrointestinal Neuroendocrine Neoplasms.

Authors:  Ajaykumar C Morani; Shiva Gupta; Khaled M Elsayes; Ahmad I Mubarak; Ahmed M Khalaf; Priya R Bhosale; Jia Sun; Corey T Jensen; Vikas Kundra
Journal:  J Comput Assist Tomogr       Date:  2022-03-04       Impact factor: 2.081

5.  Alternative lengthening of telomeres predicts site of origin in neuroendocrine tumor liver metastases.

Authors:  Epameinondas Dogeas; Georgios Karagkounis; Christopher M Heaphy; Kenzo Hirose; Timothy M Pawlik; Christopher L Wolfgang; Alan Meeker; Ralph H Hruban; John L Cameron; Michael A Choti
Journal:  J Am Coll Surg       Date:  2014-01-10       Impact factor: 6.113

Review 6.  Biochemical Diagnosis and Preoperative Imaging of Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Jessica E Maxwell; Thomas M O'Dorisio; James R Howe
Journal:  Surg Oncol Clin N Am       Date:  2015-10-31       Impact factor: 3.495

7.  Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors.

Authors:  Scott K Sherman; Jessica E Maxwell; Jennifer C Carr; Donghong Wang; Andrew M Bellizzi; M Sue O'Dorisio; Thomas M O'Dorisio; James R Howe
Journal:  Clin Exp Metastasis       Date:  2014-09-21       Impact factor: 5.150

Review 8.  Primary small-bowel malignancy: update in tumor biology, markers, and management strategies.

Authors:  Santosh Shenoy
Journal:  J Gastrointest Cancer       Date:  2014-12

9.  Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group.

Authors:  Rachel P Riechelmann; Rui F Weschenfelder; Frederico P Costa; Aline Chaves Andrade; Alessandro Bersch Osvaldt; Ana Rosa P Quidute; Allan Dos Santos; Ana Amélia O Hoff; Brenda Gumz; Carlos Buchpiguel; Bruno S Vilhena Pereira; Delmar Muniz Lourenço Junior; Duilio Reis da Rocha Filho; Eduardo Antunes Fonseca; Eduardo Linhares Riello Mello; Fabio Ferrari Makdissi; Fabio Luiz Waechter; Francisco Cesar Carnevale; George B Coura-Filho; Gustavo Andrade de Paulo; Gustavo Colagiovanni Girotto; João Evangelista Bezerra Neto; João Glasberg; Jose Claudio Casali-da-Rocha; Juliana Florinda M Rego; Luciana Rodrigues de Meirelles; Ludhmila Hajjar; Marcos Menezes; Marcello D Bronstein; Marcelo Tatit Sapienza; Maria Candida Barisson Villares Fragoso; Maria Adelaide Albergaria Pereira; Milton Barros; Nora Manoukian Forones; Paulo Cezar Galvão do Amaral; Raphael Salles Scortegagna de Medeiros; Raphael L C Araujo; Regis Otaviano França Bezerra; Renata D'Alpino Peixoto; Samuel Aguiar; Ulysses Ribeiro; Tulio Pfiffer; Paulo M Hoff; Anelisa K Coutinho
Journal:  Ecancermedicalscience       Date:  2017-01-26

10.  Synchronous Peripancreatic Lymph Node Gastrinoma and Gastric Neuroendocrine Tumor Type 2.

Authors:  Hee Woo Lee; Jun-Won Chung; Yoon Jae Kim; Kwang Ahn Kwon; Eui Joo Kim; Keon Kuk Kim; Woon Ki Lee; Sun Jin Sym
Journal:  Clin Endosc       Date:  2016-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.